Diagnostics giant Beckman Coulter sold to Danaher for $6.8B
Danaher Corp. (NYSE:DHR) agreed to pay about $6.8 billion in cash for Beckman Coulter Inc. (NYSE:BEC), ending weeks of jockeying for the Brea, Calif.-based diagnostics player.
Danaher Corp. (NYSE:DHR) agreed to pay about $6.8 billion in cash for Beckman Coulter Inc. (NYSE:BEC), ending weeks of jockeying for the Brea, Calif.-based diagnostics player.
Several private equity firms are weighing a buyout of medical device and diagnostics maker Beckman Coulter Inc. (NYSE:BEC), according to news reports. Blackstone Group LP (NYSE:BX), Apollo Global Management LLC and Kohlberg Kravis Roberts & Co (NYSE:KKR) are among a handful of investment firms interested in the Brea, Calif.-based company after news surfaced that it was looking at strategic options, including a sale, according to Reuters.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.